Extended-spectrum β-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria

Clinical Microbiology and Infection

Volumn 10, Issue 8, 2004, Pages 752-755

  Markovska, R ^a   Schneider, I ^b   Keuleyan, E ^c   Bauernfeind, A ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b MICOER Institute   (Germany)

^c Department of Clinical Laboratory   (Bulgaria)

Author keywords

Bulgaria; CTX M 15; ESBL; Escherichia coli; Klebsiella pneumoniae; Lactamase

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTIBUTEN; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; HYDROLASE; IMIPENEM; OLIGONUCLEOTIDE; PROTEIN CTX M 15; RO 48 1220; SULBACTAM; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BULGARIA; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE SEQUENCE; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WILD TYPE;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA PNEUMONIAE;

EID: 4544346897     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.00929.x     Document Type: Article

References (20)

1. Bradford P. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microb Rev 2001; 14: 933-951.
2. Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 1990; 18: 294-298.
3. Jacoby G, Bush K. Amino acid sequences for TEM, SHV and OXA extended spectrum and inhibitor resistant beta-lactamases. http://www.lahey.org/studies/webt.htm (accessed 30 May 2003).
4. Baraniak A, Fiett J, Hryniewicz W, Nordmann P, Gniadkowski M. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland. J Antimicrob Chemother 2002; 50: 393-396.
5. Karim A, Poirel L, Nagarajan S, Nordmann P. Plasmid-mediated extended-spectrum β-lactamases (CTX-M-3 like) from India and association with insertion sequence ISEcp1. FEMS Microbiol Lett 2001; 201: 237-241.
6. Bonnet R, Dutour C, Sampaio J et al. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp240-Gly. Antimicrob Agents Chemother 2001; 45: 2269-2275.
7. Poirel L, Naas T, Thomas I, Karim A, Bingen E, Nordmann P. CTX-M-type extended-spectrum β-lactamase that hydrolyses ceftazidime through a single amino acid substitution in the omega loop. Antimicrob Agents Chemother 2001; 45: 3355-3361.
8. Bonnet R, Recule C, Baradue R et al. Effect of D240G substitution in a novel ESBL CTX-M-27. J Antimicrob Chemother 2003; 52: 29-35.
9. Neuwirth C, Siebor E, Pruneaux M et al. First isolation of CTX-M-15-producing Escherichia coli from two French patients. J Antimicrob Chemother 2003; 52: 471-473.
10. Lartigue M, Poirel L, Heritier C, Tolun V, Nordmann P. First description of CTX-M-15 producing Klebsiella pneumoniae in Turkey. J Antimicrob Chemother 2003; 53: 315-316.
11. Schneider I, Keuleyan E, Markovska R et al. Emergence of CTX-M-15 extended spectrum beta-lactamase producing Enterobacteriaceae in Bulgaria, Romania and Turkey. Clin Microbiol Infect 2003; 9(suppl 1): 94.
12. Mushtaq S, Woodford N, Potz N, Livermore D. Detection of CTX-M-15 extended-spectrum β-lactamase in the United Kingdom. J Antimicrob Chemother 2003; 52: 528-529.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 12th informational supplement. M100-S12. Wayne, PA: NCCLS, 2002.
14. Mathew M, Harris A, Marshall M, Ross G. The use of analytical isoelectric focussing for detection and identification of beta-lactamases. J Gen Microbiol 1975; 88: 169-178.
15. Bauernfeind A, Schneider I, Jungwirth R, Sahly H, Ullmann U. A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob Agents Chemother 1999; 43: 1924-1931.
16. Keuleyan E, Kaludova V, Marinova R. Comparative susceptibility to β-lactams and spectra of β-lactamases in clinical Enterobacteriaceae strains [abstract 217]. In: Program and abstracts of the 4th Biennial Conference on Chemotherapy of Infectious Diseases and Malignancies, Prague. Prague: FESCI, 1992.
17. Keuleyan E, APUA-Bulgaria ARS Study Group. Short term resistance surveillance may also be helpful [abstract MM31]. In: Program and abstracts of the 10th Congress of the Bulgarian Microbiologists with International Participation, Plovdiv. Plovdiv: Union of Scientists in Bulgaria - Bulgarian Society for Microbiology, 2002; 146.
18. Jacoby G, Vacheva-Dobrevsky R. Epidemiology of extended spectrum β-lactamases in Sofia, Bulgaria. Eur J Clin Microbiol Infect Dis 2003; 22: 385-388.
19. Subcheva S. Phenotypic and genotypic characterization of extended spectrum β-lactamases in clinical strains of Enterobacteriaceae, isolated in oncology patients. PhD thesis. National Oncology Center, 2003; 25.
20. Markova B, Popova M, Benisheva T et al. Consumption of antibiotics in Bulgaria: first results of the ESAC retrospective data collection. Clin Microbiol Infect 2003; 9(suppl 1): 357.